These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 21982514)

  • 61. Etanercept increases tumor necrosis factor-alpha level but not sFas level in patients with rheumatoid arthritis.
    Kotyla P; Jankiewicz-Ziobro K; Owczarek A; Kucharz EJ
    Isr Med Assoc J; 2015 Jan; 17(1):14-8. PubMed ID: 25739170
    [TBL] [Abstract][Full Text] [Related]  

  • 62. SPA0355, a thiourea analogue, inhibits inflammatory responses and joint destruction in fibroblast-like synoviocytes and mice with collagen-induced arthritis.
    Lee YR; Hwang JK; Lee HS; Cheon YJ; Ryu JH; Lee SI; Kwak HB; Lee SM; Kim JS; Park JW; Jeon R; Park BH
    Br J Pharmacol; 2011 Sep; 164(2b):794-806. PubMed ID: 21501144
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Inflammation-induced left ventricular fibrosis is partially mediated by tumor necrosis factor-α.
    Manilall A; Mokotedi L; Gunter S; Le Roux R; Fourie S; Flanagan CA; Millen AME
    Physiol Rep; 2021 Nov; 9(21):e15062. PubMed ID: 34713972
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Bone- and cartilage-protective effects of a monoclonal antibody against colony-stimulating factor 1 receptor in experimental arthritis.
    Toh ML; Bonnefoy JY; Accart N; Cochin S; Pohle S; Haegel H; De Meyer M; Zemmour C; Preville X; Guillen C; Thioudellet C; Ancian P; Lux A; Sehnert B; Nimmerjahn F; Voll RE; Schett G
    Arthritis Rheumatol; 2014 Nov; 66(11):2989-3000. PubMed ID: 24623505
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Treatment of psoriatic arthritis with etanercept, a tumour necrosis factor antagonist.
    Wong VK; Lebwohl MG
    Expert Opin Biol Ther; 2005 Nov; 5(11):1505-13. PubMed ID: 16255653
    [TBL] [Abstract][Full Text] [Related]  

  • 66. TNF-alpha antibodies and osteoprotegerin decrease systemic bone loss associated with inflammation through distinct mechanisms in collagen-induced arthritis.
    Saidenberg-Kermanac'h N; Corrado A; Lemeiter D; deVernejoul MC; Boissier MC; Cohen-Solal ME
    Bone; 2004 Nov; 35(5):1200-7. PubMed ID: 15542046
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Safety and efficacy of disease-modifying anti-rheumatic agents: focus on the benefits and risks of etanercept.
    Fleischmann R; Iqbal I; Nandeshwar P; Quiceno A
    Drug Saf; 2002; 25(3):173-97. PubMed ID: 11945114
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Tumour necrosis factor receptor gene therapy affects cellular immune responses in collagen induced arthritis in mice.
    Mukherjee P; Yang SY; Wu B; Song Z; Myers LK; Robbins PD; Wooley PH
    Ann Rheum Dis; 2005 Nov; 64(11):1550-6. PubMed ID: 15860512
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Repository corticotropin injection attenuates collagen-induced arthritic joint structural damage and has enhanced effects in combination with etanercept.
    Decker DA; Higgins P; Hayes K; Bollinger C; Becker P; Wright D
    BMC Musculoskelet Disord; 2020 Aug; 21(1):586. PubMed ID: 32867752
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Tumor necrosis factor alpha blockade treatment down-modulates the increased systemic and local expression of Toll-like receptor 2 and Toll-like receptor 4 in spondylarthropathy.
    De Rycke L; Vandooren B; Kruithof E; De Keyser F; Veys EM; Baeten D
    Arthritis Rheum; 2005 Jul; 52(7):2146-58. PubMed ID: 15986373
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Therapeutic effect of a novel histone deacetylase 6 inhibitor, CKD-L, on collagen-induced arthritis in vivo and regulatory T cells in rheumatoid arthritis in vitro.
    Oh BR; Suh DH; Bae D; Ha N; Choi YI; Yoo HJ; Park JK; Lee EY; Lee EB; Song YW
    Arthritis Res Ther; 2017 Jul; 19(1):154. PubMed ID: 28673326
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Alleviation of rheumatoid arthritis by cell-transducible methotrexate upon transcutaneous delivery.
    Lee SW; Kim JH; Park MC; Park YB; Chae WJ; Morio T; Lee DH; Yang SH; Lee SK; Lee SK; Lee SK
    Biomaterials; 2012 Feb; 33(5):1563-72. PubMed ID: 22098778
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Combined inhibition of tumor necrosis factor α and interleukin-17 as a therapeutic opportunity in rheumatoid arthritis: development and characterization of a novel bispecific antibody.
    Fischer JA; Hueber AJ; Wilson S; Galm M; Baum W; Kitson C; Auer J; Lorenz SH; Moelleken J; Bader M; Tissot AC; Tan SL; Seeber S; Schett G
    Arthritis Rheumatol; 2015 Jan; 67(1):51-62. PubMed ID: 25303306
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Serum levels of lipoprotein(a) and E-selectin are reduced in rheumatoid arthritis patients treated with methotrexate or methotrexate in combination with TNF-α-inhibitor.
    Hjeltnes G; Hollan I; Førre O; Wiik A; Lyberg T; Mikkelsen K; Agewall S
    Clin Exp Rheumatol; 2013; 31(3):415-21. PubMed ID: 23465067
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The case of tumour necrosis factor-alpha inhibitors in the treatment of rheumatoid arthritis: a budget impact analysis.
    Sørensen J; Andersen LS
    Pharmacoeconomics; 2005; 23(3):289-98. PubMed ID: 15836009
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Apoptotic cell infusion treats ongoing collagen-induced arthritis, even in the presence of methotrexate, and is synergic with anti-TNF therapy.
    Bonnefoy F; Daoui A; Valmary-Degano S; Toussirot E; Saas P; Perruche S
    Arthritis Res Ther; 2016 Aug; 18(1):184. PubMed ID: 27516061
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned?
    Feldmann M; Maini RN
    Annu Rev Immunol; 2001; 19():163-96. PubMed ID: 11244034
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Bosentan, an endothelin receptor antagonist, ameliorates collagen-induced arthritis: the role of TNF-α in the induction of endothelin system genes.
    Donate PB; Cunha TM; Verri WA; Junta CM; Lima FO; Vieira SM; Peres RS; Bombonato-Prado KF; Louzada P; Ferreira SH; Donadi EA; Passos GA; Cunha FQ
    Inflamm Res; 2012 Apr; 61(4):337-48. PubMed ID: 22249931
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Etanercept decreases synovial expression of tumour necrosis factor-α and lymphotoxin-α in rheumatoid arthritis.
    Neregård P; Krishnamurthy A; Revu S; Engström M; af Klint E; Catrina AI
    Scand J Rheumatol; 2014; 43(2):85-90. PubMed ID: 24313444
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Anacardic acid suppresses fibroblast-like synoviocyte proliferation and invasion and ameliorates collagen-induced arthritis in a mouse model.
    Yang GH; Zhang C; Wang N; Meng Y; Wang YS
    Cytokine; 2018 Nov; 111():350-356. PubMed ID: 30273785
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.